Jane Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.5M
- Investors
-
16
Jane General Information
Description
Developer of diagnostic tools intended to offer information and data on women's reproductive health. The company's tools use a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual samples and predict reproductive diseases in a hassle-free manner.
Contact Information
Website
www.nextgenjane.com
Formerly Known As
NextGenJane
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Primary Office
- 1090 63rd Street
- Unit 4
- Oakland, CA 94608
- United States
+1 (925) 000-0000
Jane Timeline
Jane Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 09-Jun-2022 | $1.5M | 000.00 | Completed | Generating Revenue | |
4. Grant | 23-Feb-2022 | 00.00 | 000.00 | Completed | Generating Revenue | |
3. Later Stage VC (Series A) | 29-Mar-2019 | 000 | 000.00 | 000.00 | Completed | Startup |
2. Seed Round | 09-Mar-2016 | $2.22M | $2.22M | 00.000 | Completed | Startup |
1. Accelerator/Incubator | 09-Dec-2015 | Completed | Startup |
Jane Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Jane Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of diagnostic tools intended to offer information and data on women's reproductive health. The company's tools
Other Devices and Supplies
Oakland, CA
8
As of 2022
000.00
0000000000 0
000.00
Jane Competitors (11)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | 000 | 00.000 | 00000000 | 00.000 |
0000000 | Formerly VC-backed | Boulder, CO | 0 | 000.00 | 000000&0 | 000.00 |
00000000 | Venture Capital-Backed | Toronto, Canada | 00 | 0000 | 00000000000 | 0000 |
00000000000 | Formerly VC-backed | Helsinki, Finland | 00 | 00000 | 00000000 | 00000 |
00000000 00000000 | Formerly VC-backed | Waltham, MA | 00 | 0000 | 00000000000 | 0000 |
Jane Patents
Jane Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020373103-A1 | Methods for the characterization of fluid | Pending | 01-Nov-2019 | 0000000000 | |
AU-2020376052-A1 | Methods and systems for menstrualome analysis | Pending | 01-Nov-2019 | 0000000000 | |
CA-3156531-A1 | Methods for the characterization of fluid | Pending | 01-Nov-2019 | 0000000000 | |
CA-3156520-A1 | Methods and systems for menstrualome analysis | Pending | 01-Nov-2019 | 0000000000 | |
US-20190125316-A1 | Sample collection and preservation devices, systems and methods | Pending | 13-Apr-2016 | A61B10/0045 |
Jane Executive Team (2)
Jane Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Adam Sharkawy Ph.D | Material Impact Fund | Board Member | 000 0000 |
Deborah Kilpatrick Ph.D | Material Impact Fund | Board Member | 000 0000 |
Ridhi Tariyal | Jane | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 |
Jane Signals
Jane Investors (16)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | Minority | 000 0000 | 000000 0 | |
Access Industries | Corporation | Minority | 000 0000 | 000000 0 | |
Anne Morriss | Angel (individual) | Minority | 000 0000 | 000000 0 | |
David Walt | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Deborah Kilpatrick | Angel (individual) | Minority | 000 0000 | 000000 0 |